share_log

Fulgent Genetics Analyst Ratings

Benzinga Analyst Ratings ·  Nov 18, 2022 20:31
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/18/2022 25.38% Raymond James → $45 Initiates Coverage On → Outperform
11/14/2022 39.31% Credit Suisse $65 → $50 Maintains Outperform
11/14/2022 81.11% Piper Sandler $70 → $65 Maintains Overweight
08/25/2022 81.11% Credit Suisse → $65 Initiates Coverage On → Outperform
05/16/2022 95.04% Piper Sandler $85 → $70 Maintains Overweight
01/25/2022 248.29% Oppenheimer $141 → $125 Maintains Outperform
08/10/2021 81.11% Credit Suisse $55 → $65 Maintains Underperform
03/05/2021 290.08% Piper Sandler $135 → $140 Maintains Overweight
02/01/2021 262.22% Oppenheimer $75 → $130 Maintains Outperform
01/08/2021 Credit Suisse Downgrades Neutral → Underperform
11/24/2020 BTIG Downgrades Buy → Neutral
09/25/2020 17.02% Credit Suisse $13 → $42 Maintains Neutral
08/20/2020 108.97% Oppenheimer → $75 Initiates Coverage On → Outperform
07/27/2020 -13.62% Piper Sandler $21 → $31 Maintains Overweight
06/17/2020 -41.49% Piper Sandler $18 → $21 Maintains Overweight
05/29/2020 -44.27% BTIG → $20 Initiates Coverage On → Buy
05/05/2020 -69.35% Credit Suisse $12 → $11 Maintains Neutral
11/05/2019 -65.73% Piper Sandler $9.5 → $12.3 Upgrades Neutral → Overweight
04/26/2019 Credit Suisse Downgrades Outperform → Neutral
05/09/2018 -86.07% Credit Suisse $6 → $5 Maintains Outperform
03/01/2018 Piper Sandler Downgrades Overweight → Neutral
03/01/2018 -83.28% Credit Suisse $6.5 → $6 Maintains Outperform

What is the target price for Fulgent Genetics (FLGT)?

The latest price target for Fulgent Genetics (NASDAQ: FLGT) was reported by Raymond James on November 18, 2022. The analyst firm set a price target for $45.00 expecting FLGT to rise to within 12 months (a possible 25.38% upside). 6 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Fulgent Genetics (FLGT)?

The latest analyst rating for Fulgent Genetics (NASDAQ: FLGT) was provided by Raymond James, and Fulgent Genetics initiated their outperform rating.

When is the next analyst rating going to be posted or updated for Fulgent Genetics (FLGT)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fulgent Genetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fulgent Genetics was filed on November 18, 2022 so you should expect the next rating to be made available sometime around November 18, 2023.

Is the Analyst Rating Fulgent Genetics (FLGT) correct?

While ratings are subjective and will change, the latest Fulgent Genetics (FLGT) rating was a initiated with a price target of $0.00 to $45.00. The current price Fulgent Genetics (FLGT) is trading at is $35.89, which is within the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment